Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tract Cancer”

3,279 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,279 results

Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableUnknownNCT01786122
What this trial is testing

Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients

Who this might be right for
Non-Small-Cell Lung CarcinomaDigestive System NeoplasmsBreast Neoplasms
Basque Health Service 250
Testing effectiveness (Phase 2)Study completedNCT03292757
What this trial is testing

FLOTOR Pilot Study

Who this might be right for
ChylothoraxEsophageal CancerThoracic Duct Intra-Operative Injury
Oxford University Hospitals NHS Trust 21
Testing effectiveness (Phase 2)Study completedNCT01093222
What this trial is testing

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Who this might be right for
Extrahepatic Bile Duct AdenocarcinomaGallbladder AdenocarcinomaGallbladder Adenocarcinoma With Squamous Metaplasia+6 more
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT04000802
What this trial is testing

Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers

Who this might be right for
Decision MakingQuality of Health CareNeoplasms/Therapy+1 more
Moroccan Society of Surgery 200
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT00333502
What this trial is testing

Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

Who this might be right for
CancerSolid Tumor
NewLink Genetics Corporation 62
Not applicableStudy completedNCT05266300
What this trial is testing

Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.

Who this might be right for
Adverse Drug EventColon CancerBreast Cancer+5 more
University of Southern Denmark 722
Not applicableStudy completedNCT04776837
What this trial is testing

Predicting Disease Progression and/or Recurrence in Cancer

Who this might be right for
Patient Reported Outcome MeasuresColorectal CancerPancreatic Cancer+5 more
Massachusetts General Hospital 200
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00005906
What this trial is testing

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Who this might be right for
LymphangioleiomyomatosisLymphangiomyomasPleural Effusions+1 more
National Heart, Lung, and Blood Institute (NHLBI) 4
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Not applicableUnknownNCT01527409
What this trial is testing

The Efficacy of Health Partnership Program for Cancer Patients

Who this might be right for
Breast CancerColon CancerGastric Cancer+1 more
National Cancer Center, Korea 248
Not applicableUnknownNCT03130621
What this trial is testing

Screening of Hereditary Upper Gastrointestinal Cancer in China

Who this might be right for
Improve the Screening Criteria of Chinese Hereditary Upper Gastrointestinal Tumors
Peking University 500
Not applicableUnknownNCT03763214
What this trial is testing

PTFE Stents for Treatment of Malignant Biliary Strictures

Who this might be right for
Bile Duct StrictureBile Duct CancerPancreas Cancer
Johannes Vermehren 64
Not applicableLooking for participantsNCT06147414
What this trial is testing

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Who this might be right for
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, IncludingSickle Cell DiseaseCystic Fibrosis+12 more
Assistance Publique - Hôpitaux de Paris 550
Testing effectiveness (Phase 2)Looking for participantsNCT07056777
What this trial is testing

Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer

Who this might be right for
Gastrointestinal Cancer
Zhejiang Doer Biologics Co., Ltd. 186
Early research (Phase 1)Study completedNCT05107219
What this trial is testing

GCC Agonist Signal in the Small Intestine

Who this might be right for
Barrett EsophagusGastroesophageal Reflux DiseaseMalignant Digestive System Neoplasm
University of Wisconsin, Madison 43
Load More Results